Welcome to Attomarker Ltd, a spin-out company from the University of Exeter, founded to develop a novel, label-free, array-based technology to monitor concentrations of large numbers of biomarkers in the blood to provide a differential diagnosis of disease to assist the clinical decision makers.Multiple simultaneous biomarker analysis of blood chemistry points to a new direction in diagnosis for complex conditions such as allergy or irritable bowel syndrome, or the recovery of patients from operations. The multi-marker analysis provides a view of the health of a patient, an allergy profile or a novel way to follow the recovery of a patient after a surgical procedure.
New Services Available
Attomarker launches the APEX Recovery Score Research App to test 4 new measures for monitoring recovery in hospital. The app collects data from the existing CRP time course and derives the acute phase response. The APEX Score (Acute Phase EXeter) is a new physiological score and contains the first 8-hr prediction of CRP.